Krsnaa Diagnostics Limited has informed the Exchange about Newspaper advertisement pertaining to the audited (Standalone and Consolidated) Financial Results for the quarter and year ended March 31, 2025.
KRSNAA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Krsnaa Diagnostics posted strong FY25 audited results, with consolidated total income rising about 17% to ₹7,427 million and net profit after tax jumping 37% to ₹776 million. Q4 FY25 net profit grew 10% year-on-year to ₹207 million, while basic EPS for the full year improved to ₹24.04 from ₹17.90. On a standalone basis, net profit grew even faster at around 41% to ₹828 million. The board recommended a final dividend of ₹2.75 per share on a face value of ₹5, subject to shareholder approval. Separately, the company disclosed income tax assessment orders totalling a demand of ₹513.86 million across multiple years, against which it has filed appeals and paid ₹39.27 million under protest, stating the demands are not tenable and will not materially impact financials.
Robust profit growth and a maiden/healthy dividend are positives for shareholders, likely to be viewed favourably. However, the ₹513.86 million income tax demand is a near-term overhang even though the company is contesting it, so investors should track the appeal outcome.